Photo of Dr. Carol Aghajanian

MSK is changing the way endometrial cancer is treated.

Dr. Carol Aghajanian, MSK’s Chief of Gynecologic Medical Oncology, led a clinical trial looking at treatment outcomes of patients who added immunotherapy to the current chemotherapy standard of care. The drug combination reduced both disease progression and mortality.

The findings were published in the New England Journal of Medicine and presented at the Society of Gynecologic Oncology’s annual meeting. US News & World Report and NBC News covered the study, which one oncologist called “practice-changing.”

Read more about Dr. Aghajanian’s research on the MSK website.